GlassScriptPhysician profile
Joshua B Nething
NPI 1548410772
$14,777.17
in general payments reported to CMS, 2019-2025
23 companies · $756 in 2025
The $756 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $443 · 2021: $12K · 2022: $85.98 · 2023: $364 · 2024: $548 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,667.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $11,625.37 | 2021 | |
| Boston Scientific Corporation | $511.69 | 2019-2025 | Ams 700, Axonics |
| Procept Biorobotics Corporation | $399.24 | 2021-2024 | Aquabeam System, Aquabeam Robotic System |
| Dentsply Ih INC. | $389.22 | 2020 | |
| Neotract INC. | $155.19 | 2019 | |
| Calyxo, INC. | $149.98 | 2025 | Cvac Aspiration System |
| C. R. Bard, INC. & Subsidiaries | $142.30 | 2019-2023 | Bard Urinary Drainage Bag |
| Medtronic, INC. | $137.80 | 2022-2025 | Interstim, Signia |
| Olympus America INC. | $137.02 | 2025 | Itind System |
| Coloplast Corp | $136.73 | 2024 | |
| Astellas Pharma US INC | $131.49 | 2019-2022 | |
| Biotissue Holdings INC. | $128.32 | 2025 | |
| 180 Medical, INC. | $125.91 | 2019-2024 | Gentlecath Glide |
| Progenics Pharmaceuticals, INC. | $112.73 | 2022-2025 | Pylarify |
| Janssen Scientific Affairs, LLC | $105.92 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $105.29 | 2021-2023 | Urolift |
| Blue Earth Diagnostics | $90.20 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $51.90 | 2024-2025 | Endosheath Technology |
| Abbvie INC. | $44.79 | 2022-2025 | |
| Antares Pharma, INC. | $41.21 | 2024-2025 | Xyosted |
| Pfizer INC. | $24.17 | 2025 | |
| Conmed Corporation | $20.53 | 2025 | Airseal |
| Janssen Biotech, INC. | $10.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Nething listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.